[Cutaneous leishmaniases in French Guiana]. / Les leishmanioses cutanées en Guyane française.

Cutaneous leishmaniases are endemic over the entire territory of French Guiana. At least 5 distinct Leishmania species coexist in the sylvatic ecotopes of this French territory. The present paper checks the advances in the ecological research field during the past 5 years. The current epidemiological situation and trends are detailed successively Links between the recrudescence of leishmaniases and gold-mining are highlighted. The potential adaptation of the pathogenic complexes to the newly anthropized habitats is also described.

[Trypanosomatid (Protozoa, Kinetoplastida) parasites of sloths (Mannmalia, Xenarthra)]. / Trypanosomatidés (Protozoa, Kinetoplastida) parasites des paresseux (Mammalia, Xenarthra).

Worldwide famous for their slothfulness, sloths are xenarthran mammals living in the tropical forests of the New World. In these highly biodiverse habitats, sloths are implicated in long-term interactions with many organisms. They are especially involved in the parasitic cycles of various trypanosomatids including human parasites. This review describes the different species of the genera Leishmania, Endotrypanum and Trypanosoma that infect sloths. The improvement of the preventive method efficacy against synanthropozoonotic diseases due to several of these protozoa relies on studies on the ecology and biology of wild reservoir hosts such as sloths.

Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana.

In a retrospective study set in French Guiana, the efficacy and tolerance of the intramuscular treatment of cutaneous leishmaniasis (CL) with a single injection of pentamidine isethionate, at 7 mg/kg, were compared with those observed, earlier, using two such injections (given 48 h apart). Although 83.6% of the 281 patients given two injections each were cured, the single-injection protocol was generally as effective, curing 78.8% of 137 patients. The single-injection protocol was also associated with fewer adverse effects than the two-injection. In the treatment of "difficult" cases (those with satellite papules or relatively high numbers of amastigotes in their lesions), however, the two-injection protocol appeared significantly more effective than the single-injection. In French Guiana, therefore, patients with CL should be given one injection with pentamidine isethionate and only be given a second, 48 h later, if they have satellite papules and/or relatively high numbers of amastigotes in their lesions.